1 |
Akande TO, Adeleye JO, Kadiri S, et al (2013). Insulin resistance in Nigerians with essential hypertension. Afr Health Sci, 13, 655-60.
|
2 |
Bautista LE1, Vera LM, Arenas IA, et al (2005). Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens, 19, 149-54.
DOI
|
3 |
Chang EJ, Lee SK, Song YS, et al (2014). IL-34 is associated with obesity, chronic inflammation, and insulin resistance. J Clin Endocrinol Metab, 99, 1263-71.
DOI
|
4 |
Charles KA, Kulbe H, Soper R, et al (2009). The tumorpromoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest, 119, 3011-23.
DOI
|
5 |
Chen YS, Xu SX, Ding YB, et al (2014). Colorectal cancer screening in high-risk populations: a survey of cognition among medical professionals in Jiangsu, China. Asian Pac J Cancer Prev, 14, 6487-91.
|
6 |
Chen YS, Xu SX, Ding YB, et al (2013). Helicobacter pylori infection and the risk of colorectal adenoma and adenocarcinoma: an updated meta-analysis of different testing methods. Asian Pac J Cancer Prev, 14, 7613-9.
DOI
ScienceOn
|
7 |
Cuspidi C, Rescaldani M, Tadic M, et al (2015). White-coat hypertension, as defined by ambulatory blood pressure monitoring and subclinical cardiac organ damage: a metaanalysis. J Hypertens, 33, 24-32.
DOI
|
8 |
Daniele G, Guardado Mendoza R, Winnier D, et al (2013). The inflammatory status score including IL-6, TNF- , osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol, 51, 123-31.
|
9 |
Dobrzycka B, Terlikowski SJ, Kowalczuk O, et al (2009). Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer. Eur Cytokine Netw, 20, 131-4.
|
10 |
Hage FG (2014). C-reactive protein and Hypertension. J Hum Hypertens, 28, 410-5.
DOI
|
11 |
Hashimoto K, Ikeda Y, Korenaga D, et al(2005). The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer, 103, 1856-64.
DOI
ScienceOn
|
12 |
Karakiewicz PI, Hutterer GC, Trinh QD, et al (2007). C-reactive protein is an informative predictor of renal cell carcinomaspecific mortality: a European study of 313 patients. Cancer, 110, 1241-7.
DOI
ScienceOn
|
13 |
Hefler LA, Concin N, Hofstetter G, et al(2008). Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res, 14, 710-4.
DOI
|
14 |
Hellgren MI, Daka B, Jansson PA, et al (2014). Primary care screening for individuals with impaired glucose metabolism with focus on impaired glucose tolerance. Prim Care Diabetes, doi: 10.1016/j.pcd.2014.10.009.
DOI
|
15 |
Herishanu Y, Perry C, Braunstein R, et al (2007). Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma. Eur J Haematol, 79, 150-4.
DOI
|
16 |
Koike Y, Miki C, Okugawa Y, et al(2008). Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol, 98, 540-4.
DOI
|
17 |
Lee SJ, Kim WJ, Moon SK (2009). TNF-alpha regulates vascular smooth muscle cell responses in genetic hypertension. Int Immunopharmacol, 9, 837-43.
DOI
|
18 |
Mantovani A (2009). Cancer: Inflaming metastasis. Nature, 457, 36-7.
|
19 |
Mauer J, Chaurasia B, Goldau J, et al (2014). Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol, 15, 423-30.
|
20 |
Obuchowicz A, Kniażewska M, Zmudzinska-Kitczak J, et al (2014). Concentrations of tumour necrosis factor- and its soluble receptors in the serum of teenagers with atherosclerosis risk factors: obesity or obesity combined with hypertension. J Pediatr Endocrinol Metab, 27, 1209-12.
|
21 |
Shimura T, Kitagawa M, Yamada T, et al (2012). C-reactive protein is a potential prognostic factor for metastatic gastric cancer. Anticancer Res, 32, 491-6.
|
22 |
Pine JK, Fusai KG, Young R, et al (2009). Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. Eur J Surg Oncol, 35, 605-10.
DOI
ScienceOn
|
23 |
Plomgaard P, Nielsen AR, Fischer CP, et al (2007). Associations between insulin resistance and TNF- in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia, 50, 2562-71.
DOI
|
24 |
Qian YD, Xu X, Wang L, et al (2014). Clinical safety of chemotherapy for elderly cancer patients complicated with hypertension. Asian Pac J Cancer Prev, 15, 9875-7.
DOI
|
25 |
Tsounis D, Bouras G, Giannopoulos G, et al (2014). Inflammation markers in essential hypertension. Med Chem, 10, 672-81.
DOI
|
26 |
Tosu AR, Demir S, Selcuk M, et al (2014). Comparison of inflammatory markers in non-dipper hypertension vs. dipper hypertension and in normotensive individuals: uric acid, C-reactive protein and red blood cell distribution width readings. Postepy Kardiol Interwencyjnej, 10, 98-103.
|
27 |
Wang G, Wang A, Tong W, et al (2011). Association of elevated inflammatory and endothelial biomarkers with prehypertension among Mongolians in China. Hypertens Res, 34, 516-20.
DOI
|
28 |
White KL, Schildkraut JM, Palmieri RT, et al (2012). Ovarian cancer risk associated with inherited inflammation-related variants. Cancer Res, 72, 1064-9.
DOI
|
29 |
Xiao Y, Liu J, Huang XE, et al (2014). Clinical study on fluvoxamine combined with oxycodone prolonged-release tablets in treating patients with moderate to severe cancer pain. Asian Pac J Cancer Prev, 15, 10445-9.
|
30 |
Zhang S, Xu T, Peng Y, et al (2014). Combined action of C-reactive protein and lipid profiles on risk of hypertension and prehypertension in Mongolian adults in Inner Mongolia, China. Chin Med J, 127, 2016-20.
|
31 |
Zhang J, Patel MB, Griffiths R, et al (2014). Tumor necrosis factor- produced in the kidney contributes to angiotensin II-dependent hypertension. Hypertension, 64, 1275-81.
DOI
|